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Accuracy of Dobutamine Stress 
Echocardiography in Detecting 
Coronary Artery Disease 
Pamela A. Marcovitz, MD, and William F. Armstrong, MD 
The diagnostic accuracy of dobutamine stress 
echocardiography (DSE) (incremental infused 
doses of 5,10,20 and 30 &kg/min) was evaluat- 
ed in 141 patients who underwent coronary arte- 
riography within 2 weeks of DSE. All patients 
were being evaluated for known or suspected cor- 
onary artery disease (CAD). DSE was interpreted 
blindly as normal or showing evidence of CAD, de- 
pending on the presence of resting or inducible 
wall motion abnormalities. Coronary arteriograms 
were reviewed in a blinded, quantitative fashion. 
DSE had a sensftivity of 96% for detecting pa- 
tients with CAD, and a specificity of 66%. For the 
53 patients with normal resting wall motion, sen- 
sitivity was 87% and specificity 91%. The proto- 
col was well-tolerated by all patients. In compari- 
son with wall motion analysis, 124ead electrocar- 
diograms during dobutamine infusion revealed 
ischemfc changes in only 17% of patients with 
CAD. It is concluded that DSE is a clinically useful 
and accurate means for detecting CAD, its speci- 
ficity is hindered in patients with resting wall mo- 
tion abnormalities, and it can safely be used in pa- 
tients with known cardiac disease. 
(Am J Cardiol 1992;69:1269-1273) 
From the Division of Cardiology, Department of Internal Medicine, 
School of Medicine, University of Michigan. Ann Arbor. Michigan. 
Manuscript received Decembe; 31, 199l;kised manuskipt recekd 
and accepted January 21, 1992. 
Address for reprints: William F. Armstrong, MD, Echocardiogra- 
phy Laboratory, University Hospital, UHBl F215,1500 East Medical 
Center Drive, Ann Arbor, Michigan 48109-0022. 
C ardiovascular stress testing is a frequently used technique for diagnosing occult coronary artery disease (CAD), determining prognosis in pa- 
tients after myocardial infarction and in risk stratifica- 
tion in patients with documented CAD. The limitations 
of electrocardiographic and symptom analysis during 
treadmill testing have been well-documented, and imag- 
ing with thallium scintigraphy or radionuclide ventric- 
ulography has been shown to improve the sensitivity and 
specificity of treadmill testing.’ More recently, in estab- 
lished, experienced echocardiographic laboratories, 2-d& 
mensional echocardiographic imaging was performed 
during stress testing, yielding an increased sensitivity 
and specificity equivalent to that seen with more estab- 
lished nuclear medicine techniques.2-4 For patients un- 
able to exercise, alternate strategies for cardiovascular 
stress testing are necessary. The most frequently used 
alternative strategy is vasodilator stress testing with ei- 
ther dipyridamole or adenosine, in conjunction with 
thallium perfusion imaging.5 More recently, interest 
was shown in using combined chronotropic and inotro- 
pit stimulation with dobutamine as a means of cardio- 
vascular stress testing in patients unable to exercise.6-9 
This study prospectively evaluates the clinical use and 
diagnostic accuracy of dobutamine stress echocardiog- 
raphy (DSE) in patients with known or suspected CAD. 
METHODS 
Pat&t population: Between January 1990 and May 
1991, 568 patients underwent DSE at the University of 
Michigan. Cardiac catheterization with coronary arteri- 
ography was performed in 141 of these patients within 2 
months of DSE. These patients are the subject of this 
study. Study subjects ranged in age from 32 to 83 years 
(mean 60 f 12), and 57 (41%) were women. DSE was 
performed for evaluation of chest pain of uncertain eti- 
ology in 87 patients, for stratification after myocardial 
infarction in 15, for preoperative risk assessment in 14, 
for evaluation of interventional procedures in 14 and for 
miscellaneous indications in 11. Ninety-two patients 
were receiving antianginal therapy (either a /3 blocker 
or calcium antagonist, or a combination) at the time of 
the study. Antianginal therapy was not discontinued be- 
fore the study. 
m tieaphy: All patients underwent 
cardiac catheterization (Judkins technique) with coro- 
nary arteriography within 2 months of DSE. Angio- 
grams were reviewed by experienced angiographers us- 
ing electronic calipers for measurement of vessel diame- 
ter and maximum narrowing, and for calculation of 
percent stenosis. Significant CAD was considered pres- 
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TABLE I Hemodynamic Data: Rest and Dobutamine Stress 
Non-p-Blocked p-Blocked p Value* 
Baseline systolic blood 139 f 25 122 -c 19 <O.OOl 
pressure (mm Hg) 
Stress systolic blood 154 k 34 142 k 27 0.06 
pressure (mm Hg) 
Baseline heart rate 72 f 14 63k 11 10.001 
(beats/min) 
Stress heart rate (beats/ 109 k 24 85 ? 20 <0.0001 
min) 
*Compares @-blocked and non-p-blocked values. 
ent if a major epicardial coronary artery (right, left cir- 
cumflex or left anterior descending, or a major branch 
of 1 of these distributions) had 150% diameter stenosis. 
s m protoeolr All patients were moni- 
tored continuously by a physician or registered nurse, or 
both, during the study. After a brief history and physi- 
cal examination to exclude the presence of any contrain- 
dication to stress testing, an intravenous line was begun, 
and a 12-lead electrocardiogram was obtained. Dobuta- 
mine at a concentration of 1 mg/ml was prepared and 
infused, using an infusion pump. Patients were specili- 
tally queried for development of chest pain that was 
further categorized as typical angina, atypical chest 
pain or the pain for which the study had been recom- 
mended. Additional symptoms specifically queried in- 
cluded dyspnea, palpitations, flushing, tremulousness, 
nausea and lightheadedness. A complete 2-dimensional 
echocardiogram was recorded on videotape. For study 
Lett anterlor descending distribution 





purposes, parasternal long- and short-axis, as well as ap- 
ical 4- and 2-chamber views were recorded at 5, 10, 20 
and 30 pg/kg/min of dobutamine infusion on video- 
tape. Images at baseline, 5 and 30 pg/kg/min (or peak 
dose), and 5 minutes into recovery were transferred on- 
line in digital form for display as continuous loop im- 
ages in a quadscreen format (Freeland Systems, Prism 
Imaging, Louisville, Colorado). Echocardiograms were 
recorded using commercially available 2-dimensional 
echocardiographic equipment with transducers ranging 
in frequency from 2.25 to 3.5 MHz. All studies were 
recorded on either an Advanced Technology Laboratory 
Ultra Mark IV or an Acuson XP-128/ 10. For those 
studies recorded on the Ultra Mark IV, the intrinsic 
digitizing capacity of the unit was used rather than the 
free-standing digitizing system. At the conclusion of the 
study, the quadscreen format images were transferred 
onto 3.5 inch disks for analysis. Furthermore, the 
videotape was analyzed for confirmation. All DSE was 
viewed by an experienced echocardiographer (WFA) 
with extensive experience in stress echocardiography. 
DSE was reviewed in a blinded fashion without knowl- 
edge of coronary arteriography, clinical history, electro- 
cardiographic response or symptoms during infusion. 
Echocardiographic wall motion was graded as nor- 
mal, hypokinetic, akinetic or dyskinetic, and the pres- 
ence or absence of aneurysm, thrombus or other struc- 
tural heart disease was noted. Each echocardiogram 
was reviewed for wall motion, using the aforementioned 
scheme at each phase of stress. DSE was then catego- 
rized as either: (1) normal (all segments had normal 
motion at rest and developed hyperdynamic wall motion 
during dobutamine infusion), (2) ischemic (area of hy- 
pokinesis, akinesis or dyskinesis [not present at rest] de- 
veloped during course of dobutamine infusion) or (3) 
fixed (resting abnormality was noted, which persisted in 
unchanged or worsened manner in 1 coronary segment). 
A previously described 16-segment model (Figure 1) 
was used for grading wall motion.1° Previous experience 
demonstrated that the ability to separate right coronary 
artery from left circumflex coronary stenosis using this 
scheme is limited, and for the purposes of analysis, the 
right and circumflex territories were combined as a pos- 
terior circulation for both angiographic and echocardio- 
graphic analyses.’ l
Electrocardiographic analysis: All patients had a 
1Zlead electrocardiogram recorded at rest and at each 
stage of dobutamine infusion. Electrocardiograms were 
evaluated by an experienced electrocardiographer who 
was blinded to the results of the echocardiogram. The 
resting electrocardiogram was evaluated for rhythm and 
evidence of prior myocardial infarction. Electrocardio- 
graphic changes diagnostic of myocardial ischemia were 
defined as Ll mm of horizontal or downsloping ST- 
segment depression developing from a normal baseline, 
or 12 mm of additional ST-segment depression occur- 
ring in a lead with an abnormal configuration at rest. 
RESULTS 
Symptomatic response: DSE was well-tolerated in 
most patients. The study was not prematurely terminat- 
ed for a side effect in any patient. Angina developed in 
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17 patients (12%), was not severe, and needed therapy 
with sublingual nitroglycerin in only 2. Four patients 
developed symptomatic tachypnea or dyspnea, or both; 
all had previously documented chronic obstructive lung 
disease, and none needed inhaled bronchodilators. Oth- 
er side effects were minor and self-limited, including 
anxiety, nausea without vomiting, tremulousness and 
skin tingling. 
Hemodynamic and electrocardiographic results: 
Table I outlines the hemodynamic response to dobuta- 
mine infusion in the study population, divided into those 
patients receiving @-blocker therapy and those not on 
therapy. The hemodynamic and heart rate responses 
seen were modest compared with those expected during 
exercise testing. Hypotension (>20 mm Hg decrease in 
blood pressure during protocol) occurred in 20% (568) 
of all patients studied and in 29% of those evaluated for 
this analysis. The magnitude of hypotension ranged 
from 20 to 90 mm Hg, occurred at a mean dose of 25 f 
4 pg/kg/min and was not associated with chest pain or 
shortness of breath. 
Only 19 of 109 patients (17%) with documented 
CAD had a typical ischemic response on the 1Zlead 
electrocardiogram. New onset or increasing frequency 
of ventricular premature complexes was seen in 39 pa- 
tients (28%); all were asymptomatic and returned to 
baseline frequency within 5 minutes of stopping dobuta- 
mine infusion. Five patients had supraventricular tachy- 
cardias, including 3 with atria1 fibrillation or flutter; all 
except 1 ceased within 10 minutes of stopping dobuta- 
mine infusion. 
Angiographii resultsr Significant (150% diameter 
stenosis) CAD was present in 109 patients (77%). This 
included 62 patients with l-vessel, 21 with 2-vessel and 
26 with 3-vessel CAD. Only 2 patients had left main 
coronary artery stenosis 150%, and both had narrowing 
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TABLE II Sensitivity and Specificity for Dobutamine Stress 
Echocardiography in the Detection of Coronary Artery Disease 
(n = 141) 
Sensitivity Specificity Accuracy ~7 
All patients under- 96% (105/109) 66% (21/32) 89% (126/141) 
going cardiac 
catheterization 
l-vessel disease 95% 
Multivessel disease 97% 
Patients with nor- 87% (26130) 91% (21/23) 89% (47/53) 
mal resting wall 
motion 
Anterior circulation 91% (59/65) 79% (59/75) 84% (1181141) 
Posterior circulation 94% (73178) 71% (45/63) 84% (118/141) 
TABLE Ill Sensitivity and Specificity for the Detection of 
Coronary Artery Disease in Patients Receiving Antianginal 
Therapy by Dobutamine Stress Echocardiography 
Sensitivity Specificity Accuracy 
All patients receiving p 96% (73/76) 63% (11/16) 91% (&l/92) 
blockers or calcium 
antagonists, or both 
(n = 92) 
All patients with NRWM 92% 88% 91% 
(n = 43) 
NRWM: anterior circu- 82% 97% 93% 
lation 
NRWM: posterior cir- 94% 84% 91% 
culation 
NRWM = normal resting wall motaon. 
in more distal coronary territories as well. The presence 
of CAD was known in 41 patients on the basis of prior 
myocardial infarction or previous catheterization and 
was previously undocumented in the remainder. 
Dobutamine stress echocardiography: The normal 
response to dobutamine consists of hyperdynamic mo- 
tion at peak dose, with all segments thickening and 
moving inward to a greater extent than in the corre- 
sponding rest image (Figure 2). In the presence of sig- 
nificant CAD, a wall motion abnormality develops in 
the region of the myocardium supplied by the critically 
stenosed vessel. Figure 3 depicts dyskinesis of the distal 
septum and apex in a 67-year-old woman with an 80% 
mid-left anterior descending stenosis. DSE was consis- 
tent with CAD in 105 of 109 patients with angiographic 
CAD. The sensitivity and specificity for the detection of 
CAD in the entire patient population, as well as those in 
the anterior and posterior circulations, are presented in 
Table II. Table II also shows the accuracy in those pa- 
tients with resting wall motion abnormalities compared 
with that in those in whom only new ischemic changes 
were used in the diagnosis of CAD, and in those with 
single and multivessel CAD. Table III presents the sen- 
sitivity, specificity and accuracy for patients receiving 
active antianginal therapy. 
False negative studies occurred in only 4 patients. 
The maximum heart rate during DSE was <85 beats/ 
min in 2 of these patients. A third patient had a supra- 
ventricular tachycardia during peak dobutamine infu- 
sion, increasing the complexity of wall motion analysis. 
One patient had a technically poor study. False positive 
DSE was seen in 11 patients. Clinically documented 
cardiomyopathy or other forms of organic heart disease 
were present in 9 of these patients. One patient had crit- 
ical aortic stenosis with left ventricular hypertrophy. 
The diagnosis of CAD in 7 of these 11 patients was 
based on the presence of wall motion abnormalities de- 
tected at rest (4 worsened during dobutamine infusion). 
DISCUSSION 
Relative accuracy of dohtamine stress echocardi- 
ography: In this study, the accuracy, sensitivity, speci- 
ficity and predictive value of DSE was equivalent to 
that of exercise echocardiography and competing nucle- 
ar medicine techniques. The sensitivity for detecting pa- 
tients with single and multivessel CAD (95 and 97%, 
respectively) was higher than previously reported values 
for the competing technologies’; however, the specificity 
in this patient population was only 66%. Most false posi- 
tive studies occurred in patients with wall motion abnor- 
malities at rest. The current study was a blinded evalua- 
tion of wall motion abnormalities in unselected patients 
presenting for DSE. Patients were not excluded because 
of nonischemic heart disease, and all wall motion abnor- 
malities were assumed to represent CAD. This results in 
an obvious catheterization referral bias, because pa- 
tients with an abnormal test are more likely to undergo 
arteriography than those with a normal result. When 
patients with an abnormal baseline echocardiogram are 
excluded from analysis, specificity increases to 91%. 
Advantages and limitations of dobutamine stress 
echocardiiraphy: DSE has several advantages com- 
pared with other imaging techniques. As with other 
forms of echocardiographic stress testing, its versatility 
provides substantially more baseline data than do com- 
peting forms of cardiovascular stress testing. The base- 
line echocardiogram evaluates all 4 cardiac chambers 
and all 4 cardiac valves, and provides clues as to the 
presence or absence of virtually any form of organic 
heart disease. Virtually any cardiac disease that mimics 
or masquerades as CAD is accurately and quickly de- 
tected during the course of the stress echocardiogram. 
Dobutamine (as used in this stress protocol) was 
very well-tolerated and was not associated with signifi- 
cant side effects. One of the major concerns regarding 
dobutamine infusion in patients with a high likelihood 
of CAD is that uncontrollable angina, myocardial in- 
farction or significant arrhythmias may be precipitated. 
The benign side effect profile of DSE (as used in this 
protocol) would appear to diminish those concerns. The 
number of patients who developed angina during DSE 
was small (12%), and when it occurred, angina was 
mild, needing sublingual nitroglycerin in only 2 patients. 
The incidence of induced angina is low compared with 
that in standard exercise testing. No patient had a pro- 
longed episode of ischemia or myocardial infarction. 
Malignant arrhythmias (which have been a concern in 
the use of sympathomimetic agents) were not seen in 
this study. 
An additional advantage of DSE is that it allows 
evaluation of left ventricular function and regional wall 
motion at multiple, incremental levels of left ventricular 
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stress. Because the patient remains in the supine posi- 
tion throughout the study, body position can be opti- 
mized for high-quality echocardiographic images ob- 
tained at each incremental level of stress. This is not 
feasible using post-treadmill exercise imaging, where 
chest wall and respiratory motion sometimes makes ob- 
taining consistently high-quality images difficult. Thus, 
the diagnostic yield may be higher than with post-tread- 
mill or bicycle stress echocardiography. Furthermore, 
by analysis of the precise level of stress at which an 
ischemic wall motion abnormality develops, prognostic 
information may be available.12 
The major limitation of DSE is that it relies on the 
induction of ischemia through increases in myocardial 
oxygen consumption to produce an abnormal result. 
This could theoretically lead to prolonged ischemia or 
infarction, or both. From this and previous studies, it 
appears that the magnitude of the induced ischemia is 
not sufficient to cause an escalating pattern of angina or 
myocardial infarction. An additional limitation of our 
study is that it represents a subjective evaluation of wall 
motion, rather than a detailed quantitative evaluation of 
wall motion abnormalities. The lack of quantitative data 
may hinder assessment of the precise onset of wall 
motion abnormalities. However, subjective interpreta- 
tions are obtained in most clinical laboratories, and 
(when performed by experienced echocardiographers in 
a blinded fashion) provide accurate results regarding 
the presence and location of CAD. Precise quantitation 
of the magnitude of the ischemic burden may be neces- 
sary for prognostic purposes or for evaluating the results 
of an intervention. For diagnostic purposes, a simple 
qualitative assessment of wall motion (as in this study) 
suffices, and avoids the complexity, added cost and in- 
convenience of quantitative wall thickening or endocar- 
dial motion schemes. Furthermore, there is no consen- 
sus regarding the specific quantitative technique to use. 
Comparison with other studktx DSE was first re- 
ported as a diagnostic technique by Berthe et al6 in 
1986. They evaluated 30 patients 5 to 14 days after 
myocardial infarction to assess the accuracy of DSE for 
detection of multivessel CAD. Our results for the spe- 
cific diagnosis of multivessel disease in patients with 
resting abnormalities (many of whom can be presumed 
to have had myocardial infarction) are virtually identi- 
cal to theirs. Sawada et al8 also demonstrated the diag- 
nostic use of DSE. They reported a sensitivity and speci- 
ficity for detecting patients with CAD (92 and 79%, 
respectively) that was similar to those reported here. 
The results reported here are fully in concordance with 
those of these other studies and suggest that DSE may 
have a valuable role in the evaluation of patients with 
known or suspected CAD. 
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